InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Shaff Eric D.. Director active across 1 company, notably Seres Therapeutics, Inc.. Aggregated, 14 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €1k. Activity tracked since 5 July 2022. The latest transaction was disclosed on 17 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations
Shaff Eric D. is a declarant linked to Seres Therapeutics, Inc., where he is Director. The record shows 12 filings in total, and across the sampled recent filings from 2022-07-06 to 2026-02-18, the aggregate buy and sell amounts in euros are both 0; the largest displayed filing is dated 2022-07-06 at 194975.7950574334 euros.